Companies · Biotech / Pharma

Freedom Pharmacy Operations, LLC

Atlanta · Biotech / Pharma · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Freedom Pharmacy Operations, LLC — recommendation, valuation, rhythm, risks.
$1.5M
Total raised · real
2
Rounds
5.0×
Latest step-up
Top 68%
Sector rank · raised
Seed
Latest stage · inferred · Tue Mar 09 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Freedom Pharmacy Operations, LLC looks fair against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech/pharma sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.06× the median modeled value of Seed Biotech / Pharma companies in 2019–2021 (15 peers) — value vs value, same stage and era.
  • Within the normal band (106% of peer median) for its niche.
Dormant
  • Last raise 5.3 yr ago; this sector typically re-raises about every 15 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Freedom Pharmacy Operations, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
5.5 yr record
Peak capital year was 2021 with $1.5M across 2 filings.
Market position
ahead of 33% of Biotech / Pharma peers
Capital scale is ahead of 33% of Biotech / Pharma peers; modeled value is above 57% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2021: $1.5M across 2 filings.
  • Largest single filing was $1.3M on 2021-03-09.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotech / Pharma

Freedom Pharmacy Operations, LLC is one of 227 Biotech / Pharma companies tracked from Atlanta. By capital raised it ranks in the long tail (ahead of 33% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2020
Year incorporated
2021-03-09
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2021-01-06 Raised $250K (real) Modeled valuation $9.4M (est)$250K$9.4MPre-Seed2021Seed · 2021-03-09 Raised $1.3M (real) Modeled valuation $36M (est)$1.3M$36MSeed2021+$1.3MCumulative $1.5M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$250K · 2021
Seed$1.3M · 2021

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$35.9M
Base estimate est.
$930K
Conservative case
$233.8M
Upside case
$6.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech/pharma sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $9.4M · 2021-01-062021Seed · modeled $35.9M · 2021-03-092021
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
33%
Survival probability
15% low · 51% high
1.71×/yr
Annual markup
2.24×/yr upside case
5.3 yr
Elapsed time used
5.3 yr actual, capped for stale marks
biotech/pharma
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
2 mo
Avg between rounds
Capital velocity
5.5 yr
On record since
2021
First round
2
Rounds on file
How it compares to the market

Benchmarked against 227 companies in Biotech / Pharma. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.3× of median
This company$1.5M
Sector median$5.6M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.7× of median
This company$1.3M
Sector median$1.9M
Modeled value — vs sector median (estimate, all stages) 1.2× above median
This company$35.9M
Sector median$30.5M

Raised more than 33% of sector peers (real $). Modeled value above 57% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #7 of 15.

This companyCohort peer
$10.0M$100.0M$1.0B$100K$1.0M$10.0M$100.0MCapital raised (log)rMark Bio, Inc. · Seed Raised $4.5M · modeled $114.1M (est)Massive Bio, Inc. · Seed Raised $2.5M · modeled $104.1M (est)Light Bio, Inc. · Seed Raised $2.0M · modeled $82.3M (est)Agronomed Pharmaceuticals LLC · Seed Raised $9.2M · modeled $77.3M (est)Cellix Biosciences, Inc. · Seed Raised $1.5M · modeled $61.3M (est)xD Bio, Inc. · Seed Raised $1.6M · modeled $53.1M (est)Next Frontier Biosciences, LLC · Seed Raised $8.7M · modeled $34.0M (est)Circe Biosciences Inc. · Seed Raised $1.6M · modeled $33.4M (est)Animal Biosciences, Inc. · Seed Raised $2.3M · modeled $31.6M (est)growPack Bio LLC · Seed Raised $1.0M · modeled $26.3M (est)3Bar Biologics, Inc. · Seed Raised $2.4M · modeled $26.1M (est)Freedom Pharmacy Operations, LLC (this company) Raised $1.5M · modeled $35.9M (est)Freedom Pharmacy Operations, LLC
CompanyStageRaised · realValue · estvs peer med.
rMark Bio, Inc.Seed$4.5M$114.1M3.36×
Massive Bio, Inc.Seed$2.5M$104.1M3.06×
Light Bio, Inc.Seed$2.0M$82.3M2.42×
Agronomed Pharmaceuticals LLCSeed$9.2M$77.3M2.28×
Cellix Biosciences, Inc.Seed$1.5M$61.3M1.80×
xD Bio, Inc.Seed$1.6M$53.1M1.56×
Freedom Pharmacy Operations, LLC this companySeed$1.5M$35.9M1.06×
Next Frontier Biosciences, LLCSeed$8.7M$34.0M1.00×
Circe Biosciences Inc.Seed$1.6M$33.4M0.98×
Animal Biosciences, Inc.Seed$2.3M$31.6M0.93×
growPack Bio LLCSeed$1.0M$26.3M0.77×
3Bar Biologics, Inc.Seed$2.4M$26.1M0.77×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$250K2021-01-06$1.4M$9.4M90%
Seed$1.3M2021-03-09$6.3M$35.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$250K2021-01-06
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Seed$1.3M2021-03-09
    • Came back fast: 2 mo vs the ~15 mo sector norm.
    • Round 5.0× larger than the prior — scaling up.
    • 1 investor on this round.
Intelligence
2021 ~Q2
Modeled next raise · ~2mo cadence
$3.8M
Modeled next size est.range $2.5M$6.0M
5.0×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
J. Douglas Craft3 other2021-01
Bennie Lee Harris2021-01
Jay William Trulove2021-01
Miles Douglas Marks2021-01
Thomas Douglas Estes2021-01
Registry & provenance

Freedom Pharmacy Operations, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1839907
SEC CIK
2020
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Bio Essence CorpBiotech / PharmaSeed$1.5M$14.9Msame sector · same stage
Cellix Biosciences, Inc.Biotech / PharmaSeed$1.5M$61.3Msame sector · same stage
PharmaWaste Ventures, LLCBiotech / PharmaSeed$1.4M$3.5Msame sector · same stage
Circe Biosciences Inc.Biotech / PharmaSeed$1.6M$33.4Msame sector · same stage
xD Bio, Inc.Biotech / PharmaSeed$1.6M$53.1Msame sector · same stage
Split Biosciences, Inc.Biotech / PharmaSeed$1.8M$23.0Msame sector · same stage
Base Pair Biotechnologies, Inc.Biotech / PharmaSeed$1.9M$76.6Msame sector · same stage
Trio Pharmaceuticals, Inc.Biotech / PharmaSeed$1.9M$22.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Freedom Health Management, LLCHealthtechPre-Seed$2.6M89%
Pharmacy Specialty Group, LLCBiotech / PharmaPre-Seed$5.1M84%
Olive Pharmacy, LLCBiotech / PharmaPre-Seed$5.1M83%
Freedom Wellness Inc.HealthtechSeed$6.9M83%
Singular Bio, Inc.Biotech / PharmaSeries A$220.3M82%
Evio Pharmacy Solutions, LLCBiotech / PharmaSeries A$32.5M81%
PharmaWaste Ventures, LLCBiotech / PharmaSeed$3.5M81%
Intelligent Bio Solutions Inc.Biotech / PharmaSeries A$25.8M81%
Frequently asked
How much funding has Freedom Pharmacy Operations, LLC raised?
Freedom Pharmacy Operations, LLC has raised approximately $1.5M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Freedom Pharmacy Operations, LLC's estimated valuation?
Provath's modeled valuation for Freedom Pharmacy Operations, LLC is approximately $35.9M (modeled range $930K–$233.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Freedom Pharmacy Operations, LLC at?
Freedom Pharmacy Operations, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Tue Mar 09.
What does Freedom Pharmacy Operations, LLC do and where is it based?
Freedom Pharmacy Operations, LLC operates in the Biotech / Pharma sector, based in Atlanta.
Explore related

See where Freedom Pharmacy Operations, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Freedom Pharmacy Operations, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.